Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | HBB | P68871 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6706268 | 0.81 | TP53 (0.50) | TP53HBBSMN1; SMN2 | |
| SCHEMBL22252554 | 0.80 | TSHR (0.53) | TP53HBBSMN1; SMN2 | |
| SCHEMBL22252310 | 0.76 | MGLL (0.35) | TP53SMN1; SMN2 | |
| SCHEMBL20754783 | 0.74 | — | — | |
| SCHEMBL22272189 | 0.72 | — | — | |
| SCHEMBL22252579 | 0.71 | — | — | |
| Teroxirone SCHEMBL4472568 | 0.71 | TP53 (1.00) | TP53HBBSMN1; SMN2 | |
| Teroxirone SCHEMBL4932 | 0.71 | TP53 (1.00) | TP53HBBSMN1; SMN2 | |
| Teroxirone SCHEMBL4461477 | 0.71 | TP53 (1.00) | TP53HBBSMN1; SMN2 | |
| Teroxirone SCHEMBL2097375 | 0.71 | TP53 (1.00) | TP53HBBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210380553-A1 | Method for the preparation of compounds with cyclic monothiocarbonate groups | BASF SE (DE) | 2021-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380553-A1 | Method for the preparation of compounds with cyclic monothiocarbonate groups | C1R, C1S, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | TP53 2248/4885HBB 936/4885SMN1; SMN2 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.